Clinical Trial Update: Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous immunoglobulin for inflammatory myopathies, including dermatomyositis, polymyositis, and inclusion body myositis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Inclusion Body Myositis
• Polymyositis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Dermatomyositis, Inclusion Body Myositis | Phase 2 | Status: COMPLETED